SENATE DOCKET, NO. 1506 FILED ON: 1/16/2025
SENATE . . . . . . . . . . . . . . No.
|
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Adam Gomez
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act relative to APOL1 mediated kidney disease.
_______________
PETITION OF:
Name: | District/Address: |
|
Adam Gomez | Hampden |
|
Homar Gómez | 2nd Hampshire | 1/17/2025 |
SENATE DOCKET, NO. 1506 FILED ON: 1/16/2025
SENATE . . . . . . . . . . . . . . No.
[Pin Slip] |
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Fourth General Court
(2025-2026)
_______________
An Act relative to APOL1 mediated kidney disease.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
Chapter 111 of the General Laws is hereby amended by inserting after section 244, the following section:-
Section 245. The department of public health shall conduct a review and issue a report on variants of the apolipoprotein L 1 (APOL 1) gene associated with increased risk of end-stage renal disease. The report must include:
(1) Recommendations on how to increase awareness for APOL 1, including screening and genetic testing;
(2) An analysis of strategies and funding to increase screening and genetic testing for APOL 1 in the commonwealth; and
(3) Other relevant information or issues identified by the department.
The department of public health shall file the report with the clerks of the house of representatives and the senate and the joint committee on public health no later than December 31, 2026.